Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
27
Number of overlapping holdings
49.1%
% of FMED's 62 holdings also in BMED
25.7%
% of BMED's 115 holdings also in FMED
Overlap by Weight
Sector Drift (FMED minus BMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FMED |
Weight in BMED |
Overlap | |
|---|---|---|---|---|
 |
BOSTON SCIENTIFIC CORP | 7.3% | 4.9% | 4.9% |
|
INTUITIVE SURGICAL INC | 4.5% | 4.9% | 4.5% |
 |
ARGENX SE ADR | 3.4% | 3.3% | 3.3% |
|
UCB SA | 2.8% | 2.2% | 2.2% |
|
EDWARDS LIFESCIENCES CORP | 2.2% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
FMED Overweight Relative to BMED
|
UNITEDHEALTH GROUP INC | 4.0% |
|
REGENERON PHARMACEUTICALS | 3.0% |
|
AGILON HEALTH INC | 2.8% |
|
INSULET CORP | 2.7% |
|
LIFESTANCE HEALTH GROUP, INC. | 2.6% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 2.5% |
|
VEEVA SYSTEMS INC-CLASS A | 2.4% |
|
BOSTON SCIENTIFIC CORP | 2.4% |
|
MASIMO CORPORATION | 2.3% |
|
PENUMBRA, INC. | 2.2% |
FMED Underweight Relative to BMED
|
GILEAD SCIENCES INC | -3.7% |
 |
ROCHE HOLDING AG-BR | -3.4% |
|
ABBVIE INC | -3.1% |
|
ABBOTT LABORATORIES | -2.7% |
 |
MEDTRONIC PLC | -2.3% |
|
BRISTOL-MYERS SQUIBB CO | -2.2% |
|
REPLIGEN CORP | -2.1% |
|
WATERS CORP | -2.0% |
|
BIO-TECHNE CORPORATION | -1.8% |
|
NEUROCRINE BIOSCIENCES INC | -1.5% |